Contour Neurovascular System
Commercial- Indications
- Intracranial aneurysms
Company intelligence / Profile preview
Cerus Endovascular
Oxford, England, United Kingdomstryker.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Cerus Endovascular developed and commercialized CE Marked neurovascular devices for the endovascular treatment of intracranial aneurysms. Its main products include the Contour Neurovascular System and Neqstent Coil Assisted Flow Diverter, both designed to address complex brain aneurysms with minimally invasive procedures. The company was acquired by Stryker in May 2023 to expand Stryker’s hemorrhagic stroke portfolio globally. Clinical results have supported their use as effective one-and-done therapies for certain types of cerebral aneurysms.
- Therapeutic areas
- Neurology
- Modalities
- DeviceMedical device (neurointerventional)
- Industry
- Implantable Medical Devices
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
No major external pharma/biotech partnerships disclosed; now integrated into Stryker’s global network.
Beyond the preview
Go deeper on Cerus Endovascular.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cerus Endovascular.